Media Coverage
The work done by Northwestern University Feinberg School of Medicine faculty members (and even some students) is regularly highlighted in newspapers, online media outlets and more. Below you’ll find links to articles and videos of Feinberg in the news.
-
HealthDay
–
High-Dose Statins Boost Survival: Study
In an editorial accompanying the study report, Dr. Robert Bonow and Dr. Clyde Yancy, both from Northwestern University Feinberg School of Medicine, wrote that the findings are significant. Study researchers “provide compelling evidence that statins reduce mortality even when measured at only one year of exposure and that the reduction in mortality is greater with high-intensity statin therapy,” Bonow and Yancy wrote. One caveat, however, is that the findings should be interpreted with caution because they run counter to those from randomized clinical trials, the editorial said.
-
U.S. News & World Report
–
High-Dose Statins Boost Survival: Study
In an editorial accompanying the study report, Dr. Robert Bonow and Dr. Clyde Yancy, both from Northwestern University Feinberg School of Medicine, wrote that the findings are significant. Study researchers “provide compelling evidence that statins reduce mortality even when measured at only one year of exposure and that the reduction in mortality is greater with high-intensity statin therapy,” Bonow and Yancy wrote. One caveat, however, is that the findings should be interpreted with caution because they run counter to those from randomized clinical trials, the editorial said.
-
TIME Magazine
–
You Asked: Why Does My Skin Still Break Out?
A hormonal disorder called polycystic ovary syndrome, or PCOS, may affect up to 15% of women, says Dr. Andrea Dunaif, a professor of endocrinology at Northwestern University. “In PCOS, the ovaries are making an excess of male sex hormones,” Dunaif explains. These excess hormones can stimulate oil production, which leads to breakouts, she says. How can you tell the difference between normal breakouts and something like PCOS? Dunaif says the uptick in male sex hormones associated with PCOS often leads to infrequent menstrual periods, usually eight or fewer periods per year. All-the-time acne—not minor breakouts that happen once or twice a month—is another indicator of PCOS, she says.
-
Yahoo!
–
Dry Winter Skin: Eczema, Psoriasis, and Rosacea Explained
More than 30 million Americans have eczema, or patches of red, thick, scaly, itchy skin. Older adults are at higher risk for asteatotic eczema, which often causes intense dryness and itchiness on the lower legs. Eczema crops up often in people with asthma or hay fever, but stress, dry heat, allergens, and fragrances and dyes in household products can set it off, too, says Jonathan Silverberg, M.D., director of the Northwestern Medicine Multidisciplinary Center for Eczema at Northwestern University in Chicago.
-
Business Insider
–
Some immune-boosting cancer drugs may pose rare heart risks
Studies have shown that the drug combination gives a stronger anti-cancer effect than either drug alone, but “we’ve known this is a double-edged sword” because of the risk of over-stimulating the immune system, said Dr. Jeffrey Sosman of Northwestern University in Chicago, who treated the two patients who died. “The big question is, is there enough advantage to using the combination, which is much more toxic, than a single drug,” he said.
-
CNBC
–
Some immune-boosting cancer drugs may pose rare heart risks
Studies have shown that the drug combination gives a stronger anti-cancer effect than either drug alone, but “we’ve known this is a double-edged sword” because of the risk of over-stimulating the immune system, said Dr. Jeffrey Sosman of Northwestern University in Chicago, who treated the two patients who died. “The big question is, is there enough advantage to using the combination, which is much more toxic, than a single drug,” he said.
-
ABC News
–
Some immune-boosting cancer drugs may pose rare heart risks
Studies have shown that the drug combination gives a stronger anti-cancer effect than either drug alone, but “we’ve known this is a double-edged sword” because of the risk of over-stimulating the immune system, said Dr. Jeffrey Sosman of Northwestern University in Chicago, who treated the two patients who died. “The big question is, is there enough advantage to using the combination, which is much more toxic, than a single drug,” he said.
-
The Washington Post
–
Some immune-boosting cancer drugs may pose rare heart risks
Studies have shown that the drug combination gives a stronger anti-cancer effect than either drug alone, but “we’ve known this is a double-edged sword” because of the risk of over-stimulating the immune system, said Dr. Jeffrey Sosman of Northwestern University in Chicago, who treated the two patients who died. “The big question is, is there enough advantage to using the combination, which is much more toxic, than a single drug,” he said.
-
The Associated Press
–
Some immune-boosting cancer drugs may pose rare heart risks
Studies have shown that the drug combination gives a stronger anti-cancer effect than either drug alone, but “we’ve known this is a double-edged sword” because of the risk of over-stimulating the immune system, said Dr. Jeffrey Sosman of Northwestern University in Chicago, who treated the two patients who died. “The big question is, is there enough advantage to using the combination, which is much more toxic, than a single drug,” he said.
-
PRI
–
Are on-demand, at-home blood tests better for our health?
However, some medical professionals see potential pitfalls in our increasing access to home blood testing. Shannon Haymond, an associate professor of pathology at Northwestern University, points out that we can already go to the store for pregnancy or urine drug tests, for example, and many diabetics are expert at checking their own blood glucose levels. But by and large, she thinks on-demand blood testing can lead us down the wrong road when it comes to keeping tabs on our health.
